https://nzx.com/files/attachments/267516.pdf
Cleared the shortfall at $1.215 which is a relief.
Apart from taking up my entitlement I also bought more rights on market.
PT
Printable View
https://nzx.com/files/attachments/267516.pdf
Cleared the shortfall at $1.215 which is a relief.
Apart from taking up my entitlement I also bought more rights on market.
PT
Forsyth back at it again with their coverage
They have a 12 month target on ARV some 36.4% higher than where it is trading right now (and that number is above 40 when you consider the cash dividend yield).
I suppose 'the dog' that is Arvida is back to being the cheapest on the market - just like the good old days.
https://www.odt.co.nz/business/cover...oup-reinstated
Sounds good, but it also sounds like I'll have less chance to keep handing my capital to ARV to get an above bank dividend, capital gain all via EPS accretive acquisitions... I suppose "ya can't win em' all!"
Just bought some more at 117. Still regard this as a conservative (safe) stock long-term, with a stable outlook and good potential for upside growth. Even with minimum wage impacts coming via Labour/NZ First.
A bit surprised at the bounce downwards post rights issue, but increasing my holding as a result...a possible risk, but time will tell whether that's a wise decision, or whether I've bought into a longer-term downtrend...
Wow shares now available at rights issue price. I didn't need to go to all of the effort of filling in forms!
Worth consideration at current levels, with net assets per share of around 111 cents (net tangible assets per share of around 95 cents), and earnings per share of 17.4 cents.
SPH this morning showing Forsyth Barr loading up lately... not surprising given they reckon its worth $1.61 within the next 12 months. Nice to see they are putting their money where their mouth is, just still hard to believe ARV is even more undervalued than the extremely undervalued OCA.